BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024

Company Participation - BioHarvest Sciences Inc. will participate in the Noble Capital Markets 20th Annual Emerging Growth Equity Conference on December 3, 2024 [3][4] - CEO Ilan Sobel will conduct one-on-one meetings with institutional investors and present to in-person attendees [4] Company Overview - BioHarvest Sciences Inc. specializes in Botanical Synthesis, utilizing a patented technology platform to grow active ingredients in plants without the need for the actual plants [5] - The company operates in two main business verticals: as a contract development and production organization (CDMO) for complex molecules and as a creator of proprietary nutraceutical health and wellness products [5]